Literature DB >> 8249155

Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS.

A Logan1, M Berry.   

Abstract

After injuries that penetrate the mature brain or spinal cord, damaged axons initially show a growth response, but later their regeneration is aborted as a dense permanent scar is laid down within the core of the wound. Functional recovery from such injuries is poor and morbidity is severe, particularly for those patients with spinal cord damage. Clinically, no long term therapeutic treatments have been developed that might inhibit scarring and promote neuronal growth. Consequently, the prevalence of patients permanently disabled from head and spinal cord injury is high, estimated at more than 1:1000 of the population of North America (Office of Technology Assessment USA, 1990). Ann Logan and Martin Berry define the mechanisms that underlie the wound healing response in the CNS and discuss the rationale for the development of novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249155     DOI: 10.1016/0165-6147(93)90007-7

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  Neurocan is upregulated in injured brain and in cytokine-treated astrocytes.

Authors:  R A Asher; D A Morgenstern; P S Fidler; K H Adcock; A Oohira; J E Braistead; J M Levine; R U Margolis; J H Rogers; J W Fawcett
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 2.  Inflammation in traumatic brain injury: role of cytokines and chemokines.

Authors:  R S Ghirnikar; Y L Lee; L F Eng
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

3.  Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons.

Authors:  J H Prehn; V P Bindokas; C J Marcuccilli; S Krajewski; J C Reed; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  TrkB and neurotrophin-4 are important for development and maintenance of sympathetic preganglionic neurons innervating the adrenal medulla.

Authors:  A Schober; N Wolf; K Huber; R Hertel; K Krieglstein; L Minichiello; N Kahane; J Widenfalk; C Kalcheim; L Olson; R Klein; G R Lewin; K Unsicker
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

5.  Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.

Authors:  A Casanovas; G Olmos; J Ribera; M A Boronat; J E Esquerda; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Role of elevated plasma transforming growth factor-beta1 levels in wound healing.

Authors:  M Shah; D Revis; S Herrick; R Baillie; S Thorgeirson; M Ferguson; A Roberts
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Thrombomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1.

Authors:  A Pindon; M Berry; D Hantaï
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

Review 8.  Mechanisms of radiation-induced brain toxicity and implications for future clinical trials.

Authors:  Jae Ho Kim; Stephen L Brown; Kenneth A Jenrow; Samuel Ryu
Journal:  J Neurooncol       Date:  2008-01-22       Impact factor: 4.130

9.  Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Susanna Weerth; Violeta Rus; Hegang Chen; Florin Niculescu; Katerina Soloviova; Cosmin Tegla; Adrian Gherman; Cedric S Raine; Moon L Shin; Horea Rus
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

10.  Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: in vitro simulation.

Authors:  A Faber-Elman; A Solomon; J A Abraham; M Marikovsky; M Schwartz
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.